From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

Microbicides 2001: The Search for HIV Protection

A microbiologic agent able to prevent 70% of HIV transmissions could have a have a significant impact on the course of the HIV pandemic. Although the rationale for the development of topical microbicides is epidemiologically compelling and scientifically plausible, research has been slow to get off the ground, and the product that has undergone the most detailed scrutiny, N-9, has thus far not been shown to be beneficial in preventing HIV transmission. Until recently, resources for microbicide research have been limited. However, the NIH, CDC, and USAID have developed programs to expedite clinical trials of microbicides and several candidates will soon be entering clinical trials.

Welcome to Journal Watch. The content you requested requires sign in with a username and password.

Sign In

Forgot your password?

If you do not use cookies, sign in here.

Login via Athens or your institution

Sign Up

Print subscribers

Activate your free online account for full access to all site content and features.

Other visitors

Subscribe for full access to all site content and features. ($99/year)

Purchase a site pass for full access to all articles. ($19/7 days)

Or, simply register for free access to email alerts, site features, and article archives. (FREE)

For more details on site access options, read more...

Copyright © 2001. Massachusetts Medical Society. All rights reserved.